3 years 0.36
Extreme 0.363
6.55
5 years 0.36
Extreme 0.363
288.9
10 years 0.36
Extreme 0.363
600,002.4
Manager TitleAgeSince
Chief Executive Officer - -
Chief Tech/Sci/R&D Officer - 2024-08-04
Date Insider Type Main position Quantity % Market Cap. Importance
1/23/25 Sell

Founder

2,215 0.0669%
1/23/25 Sell

Chief Financial Officer

1,255 0.0379%
1/23/25 Sell

Chief Executive Officer

3,690 0.1115%
Change 5-day change 1-year change 3-year change Capi.($)
-20.74%-.--% - - 1.52M
+1.19%+0.82%+22.92%+60.64% 256B
-0.42%+3.46%+4.97%+23.48% 163B
-1.27%+1.80%-19.11%+72.17% 155B
-1.14%-1.14%-56.01%-9.01% 65.3B
-0.99%+1.04%-15.38%-8.70% 51.93B
+0.29%+2.87%+12.37%+47.17% 52.35B
-1.48%-1.63%+6.01%+65.40% 50.75B
+0.87%+2.59%+21.08%+72.71% 50.04B
+2.76%+5.81%+33.21%+91.43% 46.03B
Average -2.09%+1.74%+1.12%+46.14% 98.94B
Weighted average by Cap. +0.03%+1.68%+3.16%+48.43%
Logo Avinger, Inc.
Avinger Inc is a United States-based company. The Company operates as a medical device company that designs, manufactures, and sells image-guided, catheter-based systems for treating peripheral artery disease (PAD). Its products are used by interventional cardiologists, vascular surgeons, and interventional radiologists in the United States and select international markets and are based on its Lumivascular platform, a system that uses optical coherence tomography (OCT) for real-time visualization inside arteries. Its products includes the Lightbox imaging console, Ocelot and Tigereye catheters for crossing blockages, and Pantheris for removing plaque.
Employees
70
  1. Stock Market
  2. Stocks
  3. AVGR Stock